OVID icon

Ovid Therapeutics
OVID

Overview Fund Activity

50 hedge funds and large institutions have $21.7M invested in Ovid Therapeutics in 2019 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 23 increasing their positions, 8 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
50
Holders Change
+3
Holders Change %
+6.38%
% of All Funds
1.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
23
Reduced
8
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BI
BVF Inc
California
+$5.83M
2
GPCM
Granite Point Capital Management
Massachusetts
+$740K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$641K
4
Renaissance Technologies
Renaissance Technologies
New York
+$545K
5
Wells Fargo
Wells Fargo
California
+$544K

Top Sellers

1
BlackRock
BlackRock
New York
-$1.32M
2
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$191K
3
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$71.4K
4
Millennium Management
Millennium Management
New York
-$54K
5
SG Americas Securities
SG Americas Securities
New York
-$46K
Name Holding Trade Value Shares
Change 		Shares
Change %
Millennium Management
51
Millennium Management
New York
– -$54K -22,286 Closed
SG Americas Securities
52
SG Americas Securities
New York
– -$46K -18,870 Closed
PPA
53
Parametric Portfolio Associates
Washington
– -$26K -10,580 Closed
UBS Group
54
UBS Group
Switzerland
– -$24K -10,101 Closed
Russell Investments Group
55
Russell Investments Group
United Kingdom
– -$1K -500 Closed
1 2
3